Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.70339 | 30 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.60559 | 26 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.69716 | 31 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.66036 | 31 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.65197 | 31 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.73188 | 29 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.71905 | 30 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.67653 | 30 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.68028 | 31 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.58648 | 26 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.81705 | 36 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.67801 | 31 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.68705 | 30 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.69368 | 31 |